• 제목/요약/키워드: Infertility women

검색결과 441건 처리시간 0.024초

Intravenous immunoglobulin G in women with reproductive failure: The Korean Society for Reproductive Immunology practice guidelines

  • Sung, Nayoung;Han, Ae Ra;Park, Chan Woo;Park, Dong Wook;Park, Joon Cheol;Kim, Na Young;Lim, Kyung Sil;Shin, Ji Eun;Joo, Chang Woo;Lee, Seung Eun;Kim, Jae Won;Lee, Sung Ki;IVIG Task Force Korean Society for Reproductive Immunology
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제44권1호
    • /
    • pp.1-7
    • /
    • 2017
  • The task force of the Korean Society for Reproductive Immunology recommends intravenous immunoglobulin G treatment in women with reproductive failure, including recurrent pregnancy loss and/or repeated implantation failure, who show cellular immune factors such as abnormal natural killer cell levels, natural killer cell cytotoxicity, and/or type 1 T helper immunity.

비폐쇄성 무정자증의 치료 (The treatment of Non-obstructive Azoospermia)

  • 서주태;박용석;김종현;이유식;전진현;이호준;손일표;강인수;전종영
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제24권1호
    • /
    • pp.95-99
    • /
    • 1997
  • Irreparable obstructive azoospermic patients can be treated successfully with microsurgical epididymal sperm aspiration(MESA) or testicular sperm extraction (TESE) by intracytoplasmic sperm injection(ICSI). Obstructive azoospermic patients generally have normal spermatogenesis. The aim of this study was to see if any spermatozoa could be retrieved from non-obstructive azoospermia and to assess the efficacy of ICSI with TESE in germinal failure. 42 non-obstructive azoospermic patients revealed no spermatozoa at all in their ejaculates, even after centrifuge. The histology of 42 patients revealed 15 Sertoli cell only Syndrome, 4 maturation arrest and 23 severe hypospermatogenesis. All patients underwent extensive multiple testicular biopsy for sperm retrieval. These patients were scheduled for ICSI using testicular spermatozoa. In 25 out of 42 non-obstructive azoospermic patients, spermatozoa were recovered from multiple testicular biopsy specimen and 11 ongoing pregnancies were achieved. There are usually some tiny foci of spermatogenesis which allow TESE with ICSI in non-obstructive azoospermia. Also these patients may have sufficient sperm in the testes for ICSI, despite extremely high FSH level and small testes.

  • PDF

한국어판 난임 낙인 측정도구의 타당도와 신뢰도 (The Reliability and Validity of Korean Version of the Infertility Stigma Scale (K-ISS))

  • 김미옥;반민경
    • 대한간호학회지
    • /
    • 제52권6호
    • /
    • pp.582-597
    • /
    • 2022
  • Purpose: This study aimed to translate the Infertility Stigma Scale (ISS) into Korean and to evaluate its reliability and validity in the Korean context. Methods: Data were collected from 350 women who underwent in vitro fertilization (IVF). Data were analyzed using SPSS WIN 25.0 and AMOS 22.0. Content validity was analyzed using the item-level content validity index (I-CVI) and scale-level content validity index/averaging (S-CVI/Ave). The preliminary survey was conducted on 20 women who had experienced IVF at least once to check the level of understanding of the tool and the time required to fill out the questionnaire. Exploratory and confirmatory factor analyses were used to test construct validity. Additionally, hypothesis-testing construct validity were tested. Cronbach's α was used to assess the reliability. Results: The Korean-ISS (K-ISS) consists of 25 items, excluding two items from the original ISS questionnaire. Exploratory factor analysis identified four factors, which explained 75.6% of the total variance. The four distinct factors were infertility stigma with self-devaluation (56.8%), public stigma (8.1%), social withdrawal (6.5%), and family stigma (4.2%). In the confirmatory factor analysis, the 25 items in the four-factor structure were validated (χ2 /df ≤ 3, RMSEA ≤ 10). The hypothesis-testing construct validity of K-ISS against FPI (r = .58~.71, p < .001) and FQI (r = - .49~- .65, p < .001) was tested and found to be significant. The internal consistency reliability of the K-ISS, assessed using Cronbach's α, was .97. Conclusion: The K-ISS has satisfactory construct validity and reliability; therefore, it can help minimize the negative impact of stigma by measuring the stigma associated with women experiencing infertility.

정상 정자 소견을 나타내는 불임 부부에서 일반적인 체외수정과 세포질내 정자주입술을 병행하는 분할 수정법의 효용성 (Efficacy of the Split Insemination Method Combining Conventional IVF and ICSI in Non-male Factor Infertile Couples with Normal Sperm Parameters)

  • 홍승범;박동욱;신미라;최수진;이선희;송인옥;전진현
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제34권4호
    • /
    • pp.305-312
    • /
    • 2007
  • 목 적: 본 연구에서는 일반적인 체외수정과 세포질내 정자주입술을 병행하여 시행하는 분할 수정법의 효용성을 정상적인 정자 소견을 나타내는 비남성요인 불임 환자의 체외수정 및 배아이식술에서 살펴보고자 하였다. 연구방법: 제일병원 아이소망센터에서 정자 소견상 결함이 없는 비남성요인 불임 환자에게 분할 수정법을 이용한 505주기의 임상 결과를 후향적으로 분석하였다. 획득된 난자는 무작위로 나누어 일반적인 체외수정이나 세포질내 정자주입술을 이용하여 수정을 시켰다. 수정란은 이식할 때까지 2$\sim$5일간 배양하였고, 잉여의 수정란과 배아는 동결보관하여 동결-융해 이식에 사용하였다. 수정 방법에 따른 임상 결과를 통계학적인 방법으로 비교하였다. 결 과: 획득된 난자의 수정율은 분할 수정법을 시행하였을 때 일반적인 체외수정보다 세포질내 정자주입술에서 통계적으로 유의하게 높게 나타났다 (52.9$\pm$28.0% vs 62.5$\pm$22.3%, p<0.01). 전체적인 수정의 실패는 분할 수정법을 시행한 505주기 중에서 단지 2주기에서만 (0.4%) 나타났으며, 수정 실패와 0$\sim$30% 이하의 수정률을 나타내는 빈도는 세포질내 정자주입술에서 일반적인 체외수정보다 통계적으로 유의하게 낮았다 (1.1% and 7.5% vs 8.5% and 22.0%, p<0.01). 분할 수정주기에서의 신선 배아와 동결-융해 배아이식 후 분만율은 각각 40.0% (185/462)와 35.0% (55/157)였으며, 일반적인 체외수정이나 세포질내 정 자주입술로 얻어진 배아의 착상률과 분만율은 유의적인 차이가 나타나지 않았다. 결 론: 결론적으로 비남성요인 불임 환자의 보조생식술에서 분할 수정법이 수정 실패와 낮은 수정율을 방지하고 성공적인 임상 결과를 제공할 수 있는 효과적인 방법으로 사료된다.

Characterization and Immortalization of Normal Human Endometrial Cells

  • Hong, In-Sun;Kim, Seok-Hyun;Kung, Mi-Kyung;Jun, Jin-Hyun;Lee, Yong-Soon;Kang, Kyung-Sun
    • 한국독성학회:학술대회논문집
    • /
    • 한국독성학회 2003년도 추계학술대회
    • /
    • pp.122-122
    • /
    • 2003
  • Endometrial tissue is an interesting model for intrinsic and extrinsic factors, ie hormones and growth factors, involved in its normal pathologic development and its cyclic growth. The endometrial cells were isolated from endometrial tissue of the proliferative phase obtained by hysterectomy and separated stromal and epithelial cells.(omitted)

  • PDF

난임 여성의 피로, 건강증진행위 및 우울의 관련성 연구 (The Relationship between Fatigue, Health-Promoting Behavior, and Depression among Infertile Women)

  • 김미옥;홍주은;이은영
    • 여성건강간호학회지
    • /
    • 제25권3호
    • /
    • pp.273-284
    • /
    • 2019
  • Purpose: As the number of infertile couples has grown, many infertile women have experienced depression during the diagnosis and treatment of their infertility. This study aimed to identify the factors related to depression in infertile women who underwent reproductive treatments. Methods: The study subjects were 149 infertile women who underwent reproductive treatments. The data were collected by self-administered questionnaires from August 1 to December 24, 2018. The questionnaire consisted of questions about fatigue, health-promoting behavior, and depression. Analyses of the descriptive statistics, t-tests, one-way analysis of variance, correlation, and multiple regression were conducted using the SPSS 25.0 Windows program. Results: Thirty-six of the women in the study (24.2%) were in the probably depressed group and 113 (75.8%) were in the definitely depressed group and 100% of the subjects experienced symptoms of depression. Depression was positively correlated with fatigue and negatively correlated with health-promoting behavior. Multiple regression analysis revealed that fatigue and interpersonal relationships were factors significantly related to depression in the model (p<.001), with an explanatory power of 42.6%. Conclusion: The results confirmed that fatigue and interpersonal relationships, which is a subfactor of health-promoting behavior, were factors related to depression. To alleviate depression in infertile women, efforts should be made to identify and reduce psychological and physical fatigue. In addition, minimizing relational difficulties that they experience during an infertility diagnosis and treatment and strengthening positive interpersonal relationships can be positive strategies to alleviate depression.

Cathepsin B in Eutopic and Ectopic Endometrial Tissues of Patients with Endometriosis

  • Kim, Chung-Hoon;Lee, You-Jeong;Kim, Jun-Bum;Lee, Young-Jin;Ahn, Jun-Woo;Kim, Sung-Hoon;Chae, Hee-Dong;Kang, Byung-Moon
    • 한국발생생물학회지:발생과생식
    • /
    • 제17권2호
    • /
    • pp.133-140
    • /
    • 2013
  • This study was performed to investigate the expression of cathepsin B mRNA and protein in eutopic and ectopic endometrial tissues of patients with endometriosis and in normal endometrial tissues and to clarify the association between the cathepsin B expression and endometriosis. A total of 40 women with histologically confirmed endometriosis were recruited for study group. For controls, 20 women undergoing operative treatment for uterine myoma, cervical intraepithelial neoplasia (CIN) or benign gynecologic conditions other than endometriosis were recruited. Eutopic endometrial tissues of both groups and ectopic endometrial tissue of study group were collected during the operations. We employed real time reverse transcriptase - polymerase chain reaction (RT-PCR) to quantify mRNA levels of cathepsin B in these tissues. Then, we performed western blot analysis to measure the protein levels of cathepsin B. The expressions of cathepsin B mRNA and protein were significantly higher in both eutopic and ectopic endometrial tissues of women with endometriosis than in endometrial tissues of controls. These data suggest that the higher expression of cathepsin B in the endometrial tissues might be associated with the development of endometriosis. In addition, eutopic endometrium itself with higher expression cathepsin B may play a pivotal role in the histogenesis of endometriosis.

한국인 다낭성 난포증후군 환자에서 SHP 유전자 변이 분석 (The Analysis of SHP (Small Heterodimer Partner) Gene Mutation in Infertile Patients with Polycystic Ovary Syndrome (PCOS) in Korea)

  • 이수만;최흥식;이숙환;한정희;남보현;곽인평;남윤성;김남근;이교원;전혜선
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제28권2호
    • /
    • pp.141-145
    • /
    • 2001
  • Objective: We inversigated Small Heterodimer Partner (SHP) gene mutation in Korean Polycystic Ovarian Syndrome (PCOS) patients. SHP protein regulates the activity of nuclear receptors which regulate the cellular development and differentiation. Recently, the mutation of SHP gene was found in the obesity and diabetes patients in Japanese group, and suggested that its mutation may involved in pathogenic mechanism of PCOS. Methods: This study was performed in 20 PCOS patients and 20 normal women. The DNAs were extracted from the peripheral bloods, and amplified at each exon (1 and 2) of SHP gene by PCR method. Subsequently, each PCR product was digested with the restriction enzyme indicated below for studying restriction fragment length polymorphism (RFLP). After enzyme digestion, the results of RFLP were compared PCOS patients with control women to find any sequence variation. Results: We examined 9 regions of exon 1 with Msp I, Pvu II, Dde I and 3 regions of exon 2 with Pst I, Dde I. There is no heterozygous or homozygous mutation in patients and control women at these restriction sites. Conclusion: The genetic analysis at our restriction sites in the SHP gene did not show any genetic variation in Korean PCOS patients. Our PCR-RFLP analysis was not covered the entire SHP gene (68 bp/1,006 bp), we need to further analysis of the entire SHP gene.

  • PDF

저성선자극호르몬 성선저하증 여성에서 보조생식술의 임신율 (ART Outcomes in WHO Class I Anovulation: A Case-control Study)

  • 한애라;박찬우;차선화;김혜옥;양광문;김진영;궁미경;강인수;송인옥
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제37권1호
    • /
    • pp.49-56
    • /
    • 2010
  • 목 적: 저성선자극호르몬 성선저하증 환자에서 보조생식술의 임신 결과에 대해 알아보고자 하였다. 연구방법: 저성선자극호르몬 성선저하증으로 진단받고 본원에서 보조생식술을 시행받은 23명을 연구군으로, 동일기간 난관요인으로 보조생식술을 시행받은 이들 중 연구군과 연령 및 체질량지수가 일치하는 120명의 여성을 대조군으로 설정하여, 이들의 의무기록을 후향적으로 열람하였다. 보조생식술 관련 여러 계측치 및 임신율, 유산율, 출산율 등을 비교 분석하였다. 결 과: 연구군의 평균 연령은 $32.7{\pm}3.3$세였고, 평균 체질량지수는 $21.0{\pm}3.2kg/m^2$였다. 생리주기 제 2~3일에 측정한 황체형성호르몬과 난포자극호르몬은 각각 $0.61{\pm}0.35$, $2.60{\pm}2.35$ mIU/ml였고, 에스트라디올은 $10.13{\pm}8.17$ pg/ml이었다. 난소자극 주기에서 사용된 생식샘자극호르몬의 총 양과 투여기간 및 hCG 투여일의 $E_2$ 수치는 연구군에서 유의하게 높았다. 보조생식술 방법에 따라 분석한 결과, 체외수정 및 배아이식 (IVF-ET) 주기에서는 연구군에서 자궁내막두께와 수정율, 출산율이 유의하게 낮았고, 유산율은 유의하게 높았으며, 그 외 난소자극 및 인공수정 (SO-IUI) 및 동결보존배아이식 (FET) 주기에서는 두 군간에 유의한 차이를 보이지 않았다. 결 론: 저성선자극호르몬 성선저하증 여성에서 생식샘자극호르몬 치료를 통한 전반적인 보조생식술의 임신율은 22.0%로 대조군의 그것과 유사하지만, 이를 위해서는 더 많은 용량의 호르몬이 필요하다. 연구군의 IVF-ET의 경우, 주기 중 현저하게 높은 $E_2$ 수치와 유의하게 얇은 자궁내막을 보이며, 더 높은 유산율과 더 낮은 생존출산율을 보여, 이의 극복을 위해 자궁내막 수용성 개선방안에 대한 연구가 추가로 필요하다.